stockrow
Friday 6 November 2026
Export SMTI’s income statement to Excel — free account
Sanara MedTech Inc.
SMTI Healthcare Medical Instruments & Supplies
Sanara MedTech Inc.’s revenue for fiscal 2025 (year ended December 2025) was $103.1 million, up 19.0% from fiscal 2024.
- Revenue
- +9.04%
- EPS
- +78.3%
- Free cash flow
- +131.3%
- Total debt
- +5.11%
Quarter to June 2026, against a year earlier
31.59
0.02
−0.06%
Follow SMTI
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 37.08 | 26.93 | 0.00 |
Piotroski F-Score |
4 | 4 | 4 | 2 | 5 | 3 | 2 | 7 | 4 | 7 |
P/S ratio |
1.95 | 3.25 | 5.22 | 6.99 | 8.99 | 18.36 | 2.92 | 0.71 | 1.06 | 1.08 |
Altman Z-Score |
2.35 | 4.11 | 7.22 | 10.87 | 20.87 | 42.09 | 4.94 | 9.37 | (24.71) | (26.97) |
P/FCF ratio |
92.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.69 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(1.26) | 0.87 | 0.44 | 0.48 | 5.69 | (3.61) | 2.65 | 3.83 | (68.70) | (70.06) |
Beneish M-Score |
(3.22) | (2.51) | (2.40) | (1.24) | (2.50) | (1.50) | (2.26) | (3.53) | (1.44) | (3.76) |
P/Operating CF |
51.04 | 302.22 | (399.41) | (496.49) | (121.59) | (484.14) | (41.20) | 39.59 | 23.73 | 10.85 |
P/B ratio |
33.96 | 7.24 | 7.60 | 7.68 | 7.20 | 49.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 23.81 | 0.00 | 48.46 | 8.53 | 104.35 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.25 | 3.43 | 5.29 | 6.81 | 8.23 | 18.36 | 2.49 | 0.86 | 1.18 | 1.18 |
EV/EBITDA |
20.09 | 46.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.98 | 41.85 | 1.18 |
EV/Operating CF |
34.14 | (12,496.15) | (105.83) | (56.18) | (41.28) | (70.94) | (13.54) | 14.56 | (57.04) | (1.10) |
EV/FCF |
106.57 | (348.62) | (83.57) | (49.54) | (35.71) | (50.40) | (7.50) | 15.39 | (43.62) | (1.09) |
Quick Ratio |
1.53 | 1.85 | 0.99 | 1.25 | 3.59 | 0.77 | 3.01 | 1.07 | 0.61 | 1.17 |
Current Ratio |
1.80 | 2.18 | 1.38 | 1.61 | 4.09 | 1.27 | 3.35 | 1.51 | 0.96 | 1.43 |
Net Debt/EBITDA |
2.55 | 2.32 | (8.50) | 0.80 | 2.69 | (0.01) | 1.91 | (0.66) | 3.66 | (3.71) |
Debt/Assets |
63.02% | 34.84% | 13.12% | 1.34% | 1.17% | 4.90% | 14.55% | 0.00% | 54.11% | 74.52% |
Debt/Equity |
7.75 | 0.79 | 0.22 | 0.02 | 0.01 | 0.08 | 0.25 | 0.00 | 11.71 | (3.82) |
Asset Turnover |
1.28 | 1.07 | 0.96 | 0.94 | 1.04 | 1.49 | 1.83 | 4.47 | 2.87 | 3.09 |
Operating CF/Net income |
(0.18) | 0.00 | 0.75 | 0.70 | 0.61 | 0.93 | 0.77 | 11.70 | (0.73) | (0.60) |
Capex/Depreciation |
(1.09) | (0.04) | (0.07) | (0.31) | (1.26) | (5.64) | (14.21) | (0.49) | (1.07) | (0.05) |
Interest Coverage |
1.08 | 0.40 | (8.86) | (43.97) | (10,537.43) | (437.79) | (25.87) | 3.50 | 0.95 | (1.56) |
| (167.53%) | (23.15%) | (9.97%) | (22.09%) | (44.02%) | (1,007.96%) | 35.72% | (0.77%) | (18.92%) | 40.41% | |
| (46.65%) | (11.93%) | (6.38%) | (16.29%) | (34.28%) | (41.60%) | (43.88%) | 2.25% | 8.76% | (38.03%) | |
ROIC |
12.92% | 1.46% | (5.36%) | (23.30%) | (38.66%) | (53.64%) | (122.50%) | 32.30% | 8.97% | (47.04%) |
Return on Tangible Assets |
(244.35%) | (52.39%) | (66.24%) | (86.03%) | (39.19%) | (268.75%) | (43.83%) | 7.53% | (1,308.16%) | (106.44%) |
Average Days of Receivables |
42.47 | 52.43 | 47.92 | 55.76 | 45.20 | 53.08 | 41.42 | 42.51 | 48.43 | 52.64 |
Research and Development Expense of Revenue |
4.92% | 3.26% | 6.36% | 7.34% | 2.31% | 0.26% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
76.34% | 82.69% | 87.70% | 100.29% | 116.19% | 119.80% | 111.05% | 87.09% | 83.67% | 86.51% |
Intangible Assets out of Total Assets |
0.30 | 0.31 | 0.66 | 0.58 | 0.13 | 0.32 | 0.13 | 0.00 | 0.05 | 0.06 |
Share Based Compensation of Revenue |
5.00% | 5.12% | 5.30% | 5.90% | 11.05% | 9.00% | 0.00% | 0.17% | 0.96% | 1.00% |
Graham Net Nets |
(0.17) | (0.06) | (0.03) | 0.00 | 0.08 | 0.00 | 0.12 | 0.09 | (0.01) | (0.14) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.65 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(18.63%) | (3.43%) | (1.27%) | (2.48%) | (3.65%) | (1.58%) | (8.86%) | 2.70% | 3.71% | (40.45%) |
Free Cash Flow Yield |
1.08% | (0.30%) | (1.21%) | (1.97%) | (2.57%) | (1.98%) | (11.40%) | 7.88% | (2.55%) | (99.89%) |
Revenue per Share |
11.96 | 10.22 | 7.85 | 5.80 | 3.29 | 2.72 | 5.52 | 4.24 | 5.66 | 5.07 |
Operating CF per Share |
0.79 | 0.00 | (0.39) | (0.70) | (0.66) | (0.70) | (1.02) | 0.25 | (0.13) | 0.38 |
Capex per Share |
(0.53) | (0.03) | (0.03) | (0.09) | (0.10) | (0.29) | (0.80) | (0.01) | (0.08) | 0.00 |
Free Cash Flow per Share |
0.25 | (0.03) | (0.42) | (0.80) | (0.76) | (0.99) | (1.82) | 0.24 | (0.20) | 0.37 |
Cash per Share |
1.92 | 1.87 | 0.62 | 1.13 | 2.54 | 0.08 | 3.10 | 0.09 | 0.42 | 0.77 |
Shareholders Equity per Share |
0.69 | 4.59 | 5.39 | 5.28 | 4.11 | 1.02 | 3.00 | 0.28 | 0.09 | (0.39) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.69 | 4.59 | 5.39 | 5.28 | 4.11 | 1.02 | 3.00 | 0.28 | 0.09 | (0.39) |
Free Cash Flow |
2.20 | (0.25) | (3.51) | (6.30) | (5.56) | (5.68) | (3.87) | 0.49 | (0.23) | 0.41 |
Working Capital |
14.92 | 18.02 | 5.24 | 7.81 | 18.59 | 0.94 | 6.22 | 0.57 | (0.08) | 0.60 |
Capital Expenditures |
(4.59) | (0.23) | (0.26) | (0.75) | (0.75) | (1.64) | (1.70) | (0.03) | (0.09) | 0.00 |
Net Current Asset Value |
(33.47) | (15.87) | (10.28) | 1.30 | 18.36 | 0.50 | 4.13 | 0.57 | (0.08) | (0.60) |
EV/EBIT |
31.72 | 236.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 35.49 | 76.29 | 1.18 |
Capex to Sales |
0.04 | 0.00 | 0.00 | 0.02 | 0.03 | 0.11 | 0.14 | 0.00 | 0.01 | 0.00 |
Price to Operating Income |
27.56 | 223.76 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.25 | 68.71 | 1.08 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
9.25 | 11.87 | 2.93 | 1.67 | 0.37 | 0.43 | 0.59 | 3.03 | 1.28 | 1.75 |
Cash ROIC |
3.21% | (0.30%) | (5.91%) | (12.23%) | (11.30%) | (83.80%) | (26.48%) | 64.11% | (12.79%) | 20.02% |
Accounts Receivable Turnover |
8.44 | 8.26 | 8.37 | 9.17 | 9.19 | 8.65 | 9.98 | 9.45 | 7.73 | 8.84 |
Accounts Payable Turnover |
3.89 | 4.61 | 4.58 | 6.30 | 4.25 | 3.59 | 4.04 | 3.56 | 2.61 | 3.28 |
Inventory Turnover |
2.24 | 2.18 | 1.90 | 2.27 | 1.45 | 1.71 | 2.00 | 1.45 | 1.52 | 2.49 |
Average Days of Payables |
113.50 | 68.64 | 93.05 | 81.87 | 93.81 | 111.72 | 122.60 | 82.63 | 129.29 | 128.38 |
Days of Inventory on Hand |
191.63 | 123.45 | 219.27 | 203.65 | 323.47 | 259.27 | 225.31 | 199.31 | 322.16 | 134.81 |
Average Receivables |
12.22 | 10.49 | 7.77 | 5.00 | 2.63 | 1.80 | 1.18 | 0.93 | 0.82 | 0.62 |
Average Payables |
1.93 | 1.77 | 1.71 | 1.01 | 0.54 | 0.45 | 0.30 | 0.24 | 0.31 | 0.29 |
Average Inventory |
3.35 | 3.74 | 4.13 | 2.80 | 1.60 | 0.95 | 0.61 | 0.59 | 0.53 | 0.38 |
Average Assets |
80.52 | 80.98 | 67.45 | 48.72 | 23.11 | 10.47 | 6.41 | 1.96 | 2.19 | 1.78 |
Average Common Equity |
22.42 | 41.75 | 43.15 | 35.94 | 18.00 | 0.43 | (7.88) | (5.77) | (1.02) | (1.68) |
Columns are period end dates · fundamentals updated 26 Oct 2026